Target intelligence / Profile preview

Down syndrome cell adhesion molecule (DSCAM)

Target
DSCAM
Molecular classification
Cell adhesion molecule, Immunoglobulin superfamily, Transmembrane protein, Other (alternative splicing variant, notably in invertebrates)
01

Overview

Down syndrome cell adhesion molecule (DSCAM) is a member of the immunoglobulin superfamily of cell adhesion molecules, primarily involved in the development and wiring of the nervous system. In vertebrates, DSCAM is crucial for axonal pathfinding, dendritic patterning, neuron self-avoidance, and synaptic targeting by mediating homophilic cell-cell adhesion in a highly specific manner[3][5][6][7]. Alternative splicing of DSCAM, especially in invertebrates such as Drosophila, generates an extraordinary diversity of isoforms that enable fine-tuned neuronal identity and contact specificity, with over 38,000 possible variants described in some species[1][2][7]. In humans, DSCAM is encoded by a gene on chromosome 21 and its overexpression, as seen in trisomy 21, contributes to the altered neural development observed in Down syndrome[5][7]. DSCAM modulates cell adhesion by weakening cadherin-mediated interactions to ensure appropriate neuronal migration and spacing[5]. Despite its clear developmental functions, no drugs currently target DSCAM, nor is it used as a biomarker to date. Its dysfunction is linked with neurodevelopmental disorders, and animal models lacking DSCAM exhibit severe deficits in neural connectivity and embryonic morphogenesis[3][5][6].

Other names
Cell adhesion molecule DSCAMDSCAMCHD2-42CHD2-52CHD2Down syndrome cell adhesion moleculeDSCAM1 (in invertebrates)Down's syndrome cell adhesion molecule
02

Biological functions

Neural development (including axon guidance, dendritic self-avoidance, branching, and synaptic formation)Cell adhesion (mediating homophilic binding between neurons)Neuronal self-recognition and avoidanceMorphogenetic movement during embryogenesisRegulation of cell adhesion (modulating cadherin-mediated adhesion)
03

Disease associations

Neurodevelopmental disorder (notably Down syndrome)Potential role in other neuropsychiatric and neurodevelopmental conditionsOther (roles in neuroanatomical defects linked to neural network wiring deficits)
04

Safety considerations

DSCAM overexpression is implicated in the neural abnormalities of Down syndromeAltered gene dosage can disrupt neural development and migrationLoss-of-function can lead to profound neurodevelopmental defects, including impaired arborization and neural circuit formation

Beyond the preview

Go deeper on Down syndrome cell adhesion molecule (DSCAM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Down syndrome cell adhesion molecule (DSCAM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call